Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs)
$61.33
neg -0.66
-1.10%
Today's Range: 61.17 - 62.85 | BMY Avg Daily Volume: 6,179,600
Last Update: 01/28/15 - 3:59 PM EST
Volume: 6,288,979
YTD Performance: 5.01%
Open: $62.42
Previous Close: $61.99
52 Week Range: $46.30 - $64.44
Oustanding Shares: 1,658,776,491
Market Cap: 103,607,179,628
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 1
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.06 2.06 2.06 2.03
Latest Dividend: 0.37
Latest Dividend Yield: 2.37%
Dividend Ex-Date: 12/30/14
Price Earnings Ratio: 38.56
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
38.56 38.40 26.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
15.80% 24.68% 91.98%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.00 -0.16 -0.06
Net Income 3.20 -0.43 -0.17
EPS 32.80 -0.13 -0.05
Earnings for BMY:
EBITDA 3.86B
Revenue 16.39B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.47 $0.41 $1.61 $2.22
Number of Analysts 2 2 5 10
High Estimate $0.49 $0.42 $1.69 $2.48
Low Estimate $0.44 $0.39 $1.55 $2.09
Prior Year $0.46 $0.48 $1.85 $1.61
Growth Rate (Year over Year) 1.09% -15.62% -12.97% 37.70%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Christopher Versace

 | Jan 27, 2015 | 3:55 PM EST

After lightening up dollar-sensitive positions, I can ride out the week.

By

Jim Cramer

 | Jan 26, 2015 | 6:47 AM EST

It's a positive for our markets, not a negative.

By

Jim Cramer

 | Jan 15, 2015 | 3:40 PM EST

Use the overall weakness to pick up the America First stocks.

By

Jim Cramer

 | Jan 12, 2015 | 11:19 AM EST

Low P/E multiples just aren't any protection.

By

Gary Dvorchak

 | Dec 26, 2014 | 9:30 AM EST

Last chance this year to round out your income generation.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

By

Jim Cramer

 | Dec 9, 2014 | 1:59 PM EST

This market is a good team facing a tough opponent on the road.

By

Jim Cramer

 | Dec 3, 2014 | 3:59 PM EST

An immense market rotation is happening.

By

Jim Cramer

 | Dec 1, 2014 | 4:01 PM EST

There's too much good that happens with energy prices going lower.

bearishBristol-Myers downgraded at Morgan Stanley

Nov 13, 2014 | 7:28 AM EST

BMY downgraded to Equal-weight from Overweight, said Morgan Stanley. Stock is now discounting higher odds of success for new drug in development, creating unbalanced risk-reward dynamic.

Kulicke & Soffa(+7%)is in full breakout mode today. The stock opened with an ups...
Seemed as if comments related to inflation were a table setter in pushing out the first ra...
While many are concerned about a negative reaction if the Fed doesn't hint at pushing out ...
We are nearly to the Fed decision and this time around expectations for what's to come are...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.